Oncolytics Biotech Inc. (ONCY)
NCM · Common · CUSIP 682310875
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ONCY and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
682310875
Market Cap
Micro Cap
Previous Symbol
ONCYD (changed 5/31/2018)
Business: Oncolytics Biotech Inc. is a biotechnology company developing REOLYSIN, also known as pelareorep, an intravenously delivered immuno-oncolytic virus.

Company Contact

CEO
Jared Kelly
CFO
Kirk J. Look
Headquarters
4350 Executive Drive, Suite 325, San Diego, CA
Phone
403-670-7377
Investor Relations
Timothy McCarthy, LifeSci Advisors · 917-679-9282 · tim@lifesciadvisors.com
General Email
info@oncolytics.ca
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »